ClinicalTrials.Veeva

Menu

Randomised Controlled Study of Popofol Versus Midazolam as Sedation in Endoscopy With Advanced Liver Disease.

S

Sherief Abd-Elsalam

Status and phase

Unknown
Phase 4

Conditions

Liver Diseases

Treatments

Drug: Midazolam
Drug: Fentanyl
Drug: Propofol

Study type

Interventional

Funder types

Other

Identifiers

NCT03063866
Sameh 1

Details and patient eligibility

About

Gastrointestinal endoscopy is a frequent procedure in the patients with advanced liver disease. It requires variable degree of sedation ranging from minimal sedation to general anesthesia aiming for relieving pain, anxiety, and bad memories of the procedure.

In conscious sedation, patients are able to make purposeful responses to auditory and tactile clues, with maintenance of ventilatory and circulatory stability. while, in deep sedation, patients respond only to painful stimuli, and airway support is frequently required. At the level of general anesthesia, patients are unresponsive, and airway support is mandatory.

Full description

The aim of this study is to compare use of propofol or midazolam as sedative for patients with advanced liver disease presented for gastrointestinal endoscopy.

Enrollment

100 estimated patients

Sex

All

Ages

40 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged between 40 and 60 years old.
  • With Child score B or C
  • Presented for elective gastrointestinal endoscopy

Exclusion criteria

  • Emergent condition like hematemesis.
  • Patients with moderate to severe hepatic encephalopathy.
  • Patients with hepatopulmonary syndrome.
  • Patients with known or suspected hypersensitivity to the used medication were also excluded from the study.

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups

M group
Active Comparator group
Description:
Midazolam 3 mg i.v added to fentanyl 0.5 ug/kg
Treatment:
Drug: Fentanyl
Drug: Midazolam
P Group
Active Comparator group
Description:
Propofol 1 mg/kg i.v added to fentanyl 0.5 ug/kg i.v
Treatment:
Drug: Propofol
Drug: Fentanyl

Trial contacts and locations

1

Loading...

Central trial contact

Sherief Abd-Elsalam, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems